A citation-based method for searching scientific literature

Fiona Pachl, Patrik Plattner, Benjamin Ruprecht, Guillaume Médard, Norbert Sewald, Bernhard Kuster. J Proteome Res 2013
Times Cited: 20







List of co-cited articles
89 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.
Marcus Bantscheff, Dirk Eberhard, Yann Abraham, Sonja Bastuck, Markus Boesche, Scott Hobson, Toby Mathieson, Jessica Perrin, Manfred Raida, Christina Rau,[...]. Nat Biotechnol 2007
763
55

Mass spectrometry-based proteomics in preclinical drug discovery.
Markus Schirle, Marcus Bantscheff, Bernhard Kuster. Chem Biol 2012
91
35

The protein kinase complement of the human genome.
G Manning, D B Whyte, R Martinez, T Hunter, S Sudarsanam. Science 2002
35

A new chemical probe for quantitative proteomic profiling of fibroblast growth factor receptor and its inhibitors.
Xin Ku, Stephanie Heinzlmeir, Xiaofeng Liu, Guillaume Médard, Bernhard Kuster. J Proteomics 2014
9
77

New affinity probe targeting VEGF receptors for kinase inhibitor selectivity profiling by chemical proteomics.
Xin Ku, Stephanie Heinzlmeir, Dominic Helm, Guillaume Médard, Bernhard Kuster. J Proteome Res 2014
15
46

A quantitative analysis of kinase inhibitor selectivity.
Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, Paul Gallant, Corey E Atteridge, Brian T Campbell, Katrina W Chan, Pietro Ciceri, Mindy I Davis, Philip T Edeen,[...]. Nat Biotechnol 2008
30

Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling.
Luxi Zhang, Ian P Holmes, Falko Hochgräfe, Scott R Walker, Naveid A Ali, Emily S Humphrey, Jianmin Wu, Melanie de Silva, Wilhelmus J A Kersten, Theresa Connor,[...]. J Proteome Res 2013
32
30

Comparing immobilized kinase inhibitors and covalent ATP probes for proteomic profiling of kinase expression and drug selectivity.
Simone Lemeer, Corina Zörgiebel, Benjamin Ruprecht, Kristian Kohl, Bernhard Kuster. J Proteome Res 2013
38
30

Comprehensive analysis of kinase inhibitor selectivity.
Mindy I Davis, Jeremy P Hunt, Sanna Herrgard, Pietro Ciceri, Lisa M Wodicka, Gabriel Pallares, Michael Hocker, Daniel K Treiber, Patrick P Zarrinkar. Nat Biotechnol 2011
30

Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.
James S Duncan, Martin C Whittle, Kazuhiro Nakamura, Amy N Abell, Alicia A Midland, Jon S Zawistowski, Nancy L Johnson, Deborah A Granger, Nicole Vincent Jordan, David B Darr,[...]. Cell 2012
483
30

Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Theonie Anastassiadis, Sean W Deacon, Karthik Devarajan, Haiching Ma, Jeffrey R Peterson. Nat Biotechnol 2011
559
25

In situ kinase profiling reveals functionally relevant properties of native kinases.
Matthew P Patricelli, Tyzoon K Nomanbhoy, Jiangyue Wu, Heidi Brown, David Zhou, Jianming Zhang, Subadhra Jagannathan, Arwin Aban, Eric Okerberg, Chris Herring,[...]. Chem Biol 2011
227
25

Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor.
Melissa Dumble, Ming-Chih Crouthamel, Shu-Yun Zhang, Michael Schaber, Dana Levy, Kimberly Robell, Qi Liu, David J Figueroa, Elisabeth A Minthorn, Mark A Seefeld,[...]. PLoS One 2014
76
25

Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.
Zhixiang Wu, Jessica B Doondeea, Amin Moghaddas Gholami, Melanie C Janning, Simone Lemeer, Karl Kramer, Suzanne A Eccles, Susanne M Gollin, Reidar Grenman, Axel Walch,[...]. Mol Cell Proteomics 2011
57
20

Chemoproteomic approaches to drug target identification and drug profiling.
Marcus Bantscheff, Gerard Drewes. Bioorg Med Chem 2012
62
20

Functional interrogation of the kinome using nucleotide acyl phosphates.
Matthew P Patricelli, A Katrin Szardenings, Marek Liyanage, Tyzoon K Nomanbhoy, Min Wu, Helge Weissig, Arwin Aban, Doris Chun, Stephen Tanner, John W Kozarich. Biochemistry 2007
294
20

An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.
Klaus Godl, Josef Wissing, Alexander Kurtenbach, Peter Habenberger, Stephanie Blencke, Heidrun Gutbrod, Kostadinos Salassidis, Matthias Stein-Gerlach, Andrea Missio, Matt Cotten,[...]. Proc Natl Acad Sci U S A 2003
288
20

Proteomics strategy for quantitative protein interaction profiling in cell extracts.
Kirti Sharma, Christoph Weber, Michaela Bairlein, Zoltán Greff, György Kéri, Jürgen Cox, Jesper V Olsen, Henrik Daub. Nat Methods 2009
96
20

Large-scale proteomics analysis of the human kinome.
Felix S Oppermann, Florian Gnad, Jesper V Olsen, Renate Hornberger, Zoltán Greff, György Kéri, Matthias Mann, Henrik Daub. Mol Cell Proteomics 2009
228
20

Targeting cancer with small molecule kinase inhibitors.
Jianming Zhang, Priscilla L Yang, Nathanael S Gray. Nat Rev Cancer 2009
20


Optimized chemical proteomics assay for kinase inhibitor profiling.
Guillaume Médard, Fiona Pachl, Benjamin Ruprecht, Susan Klaeger, Stephanie Heinzlmeir, Dominic Helm, Huichao Qiao, Xin Ku, Mathias Wilhelm, Thomas Kuehne,[...]. J Proteome Res 2015
72
20

Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling.
Klaus Godl, Oliver J Gruss, Jan Eickhoff, Josef Wissing, Stephanie Blencke, Martina Weber, Heidrun Degen, Dirk Brehmer, László Orfi, Zoltán Horváth,[...]. Cancer Res 2005
87
15

A public-private partnership to unlock the untargeted kinome.
Stefan Knapp, Paulo Arruda, Julian Blagg, Stephen Burley, David H Drewry, Aled Edwards, Doriano Fabbro, Paul Gillespie, Nathanael S Gray, Bernhard Kuster,[...]. Nat Chem Biol 2013
101
15

Discovery of novel targets of quinoline drugs in the human purine binding proteome.
Paul R Graves, Jesse J Kwiek, Patrick Fadden, Rupa Ray, Klaas Hardeman, Andrew M Coley, Michael Foley, Timothy A J Haystead. Mol Pharmacol 2002
157
15

Kinase inhibitor profiling using chemoproteomics.
Markus Schirle, Eugene C Petrella, Scott M Brittain, David Schwalb, Edmund Harrington, Ivan Cornella-Taracido, John A Tallarico. Methods Mol Biol 2012
10
30

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.
Jiannong Li, Uwe Rix, Bin Fang, Yun Bai, Arthur Edwards, Jacques Colinge, Keiryn L Bennett, Jingchun Gao, Lanxi Song, Steven Eschrich,[...]. Nat Chem Biol 2010
200
15


Affinity-based probes based on type II kinase inhibitors.
Pratistha Ranjitkar, B Gayani K Perera, Danielle L Swaney, Sanjay B Hari, Eric T Larson, Ratika Krishnamurty, Ethan A Merritt, Judit Villén, Dustin J Maly. J Am Chem Soc 2012
35
15

Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells.
U Kruse, C P Pallasch, M Bantscheff, D Eberhard, L Frenzel, S Ghidelli, S K Maier, T Werner, C M Wendtner, G Drewes. Leukemia 2011
61
15


A small molecule-kinase interaction map for clinical kinase inhibitors.
Miles A Fabian, William H Biggs, Daniel K Treiber, Corey E Atteridge, Mihai D Azimioara, Michael G Benedetti, Todd A Carter, Pietro Ciceri, Philip T Edeen, Mark Floyd,[...]. Nat Biotechnol 2005
15

Oncogenic kinase signalling.
P Blume-Jensen, T Hunter. Nature 2001
15

Target profiling of small molecules by chemical proteomics.
Uwe Rix, Giulio Superti-Furga. Nat Chem Biol 2009
381
15

Global proteome analysis of the NCI-60 cell line panel.
Amin Moghaddas Gholami, Hannes Hahne, Zhixiang Wu, Florian Johann Auer, Chen Meng, Mathias Wilhelm, Bernhard Kuster. Cell Rep 2013
198
15

Affinity profiling of the cellular kinome for the nucleotide cofactors ATP, ADP, and GTP.
Isabelle Becher, Mikhail M Savitski, Maria Fälth Savitski, Carsten Hopf, Marcus Bantscheff, Gerard Drewes. ACS Chem Biol 2013
51
15

Inhibitor hijacking of Akt activation.
Tatsuya Okuzumi, Dorothea Fiedler, Chao Zhang, Daniel C Gray, Brian Aizenstein, Randy Hoffman, Kevan M Shokat. Nat Chem Biol 2009
205
15

Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models.
Jie Lin, Deepak Sampath, Michelle A Nannini, Brian B Lee, Michael Degtyarev, Jason Oeh, Heidi Savage, Zhengyu Guan, Rebecca Hong, Robert Kassees,[...]. Clin Cancer Res 2013
157
15

MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.
Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru, Katsuyoshi Miyama, Shunsuke Taguchi, Kyoko Tsujioka, Yoko Ueno, Harold Hatch, Pradip K Majumder, Bo-Sheng Pan,[...]. Mol Cancer Ther 2010
626
15

Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer.
Khanh Do, Giovanna Speranza, Rachel Bishop, Sonny Khin, Larry Rubinstein, Robert J Kinders, Manuel Datiles, Michelle Eugeni, Michael H Lam, L Austin Doyle,[...]. Invest New Drugs 2015
75
15

A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.
Azadeh Cheraghchi-Bashi, Christine A Parker, Ed Curry, Jean-Frederic Salazar, Hatice Gungor, Azeem Saleem, Paula Cunnea, Nona Rama, Cristian Salinas, Gordon B Mills,[...]. Oncotarget 2015
14
21

Systematic identification of the HSP90 candidate regulated proteome.
Zhixiang Wu, Amin Moghaddas Gholami, Bernhard Kuster. Mol Cell Proteomics 2012
75
10

Mass spectrometry approaches to monitor protein-drug interactions.
Nico Zinn, Carsten Hopf, Gerard Drewes, Marcus Bantscheff. Methods 2012
14
14

Quantitative mass spectrometry in proteomics: a critical review.
Marcus Bantscheff, Markus Schirle, Gavain Sweetman, Jens Rick, Bernhard Kuster. Anal Bioanal Chem 2007
10

Quantitative mass spectrometry in proteomics.
Marcus Bantscheff, Bernhard Kuster. Anal Bioanal Chem 2012
23
10

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.
Marcus Bantscheff, Carsten Hopf, Mikhail M Savitski, Antje Dittmann, Paola Grandi, Anne-Marie Michon, Judith Schlegl, Yann Abraham, Isabelle Becher, Giovanna Bergamini,[...]. Nat Biotechnol 2011
424
10

Chemical tools for activity-based proteomics.
Miriam C Hagenstein, Norbert Sewald. J Biotechnol 2006
34
10


Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology.
S P Gygi, G L Corthals, Y Zhang, Y Rochon, R Aebersold. Proc Natl Acad Sci U S A 2000
993
10

Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.
Henrik Daub, Jesper V Olsen, Michaela Bairlein, Florian Gnad, Felix S Oppermann, Roman Körner, Zoltán Greff, György Kéri, Olaf Stemmann, Matthias Mann. Mol Cell 2008
457
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.